FR2207712A1 - - Google Patents

Info

Publication number
FR2207712A1
FR2207712A1 FR7341450A FR7341450A FR2207712A1 FR 2207712 A1 FR2207712 A1 FR 2207712A1 FR 7341450 A FR7341450 A FR 7341450A FR 7341450 A FR7341450 A FR 7341450A FR 2207712 A1 FR2207712 A1 FR 2207712A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7341450A
Other languages
French (fr)
Other versions
FR2207712B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of FR2207712A1 publication Critical patent/FR2207712A1/fr
Application granted granted Critical
Publication of FR2207712B1 publication Critical patent/FR2207712B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7341450A 1972-11-24 1973-11-21 Expired FR2207712B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30953972A 1972-11-24 1972-11-24
US371452A US3875229A (en) 1972-11-24 1973-06-19 Substituted carboxanilides

Publications (2)

Publication Number Publication Date
FR2207712A1 true FR2207712A1 (enExample) 1974-06-21
FR2207712B1 FR2207712B1 (enExample) 1976-12-03

Family

ID=26976880

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341450A Expired FR2207712B1 (enExample) 1972-11-24 1973-11-21

Country Status (12)

Country Link
US (1) US3875229A (enExample)
JP (1) JPS4981332A (enExample)
BG (1) BG21392A3 (enExample)
DD (1) DD110856A5 (enExample)
DE (1) DE2357757A1 (enExample)
ES (1) ES420688A1 (enExample)
FR (1) FR2207712B1 (enExample)
GB (1) GB1446084A (enExample)
HU (1) HU169277B (enExample)
IE (1) IE38530B1 (enExample)
IL (1) IL43664A0 (enExample)
NL (1) NL7315903A (enExample)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230483A (en) * 1977-06-21 1980-10-28 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl carbamates and thiocarbamates and their use as herbicides
US4356026A (en) * 1977-06-21 1982-10-26 Stauffer Chemical Company Substituted cyclopropylmethoxy phenyl ureas and their use as herbicides
US4149874A (en) * 1977-06-21 1979-04-17 Stauffer Chemical Company Substituted cyclopropylmethoxy anilides and their use as herbicides
DE2862100D1 (en) * 1977-10-12 1983-01-05 Ici Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
DK529378A (da) * 1978-01-09 1979-07-10 Shell Int Research Anilidderivater
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
US4921941A (en) * 1987-07-01 1990-05-01 Schering Corporation Orally active antiandrogens
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
WO1998022432A1 (en) * 1996-11-18 1998-05-28 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US7518013B2 (en) * 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
US7759520B2 (en) * 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6492554B2 (en) 2000-08-24 2002-12-10 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
US20050038110A1 (en) * 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US6160011A (en) * 1997-05-30 2000-12-12 The University Of Tennessee Research Corporation Non-steroidal agonist compounds and their use in male hormone therapy
WO1998055153A1 (en) * 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US6998500B2 (en) * 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7919647B2 (en) * 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US8445534B2 (en) * 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
GEP20053586B (en) 2000-08-24 2005-07-25 Univ Tennessee Res Corp Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
US8008348B2 (en) * 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US7102026B2 (en) * 2001-06-13 2006-09-05 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparing and isolating rac-bicalutamide and its intermediates
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
WO2003005889A2 (en) * 2001-07-10 2003-01-23 Ams Research Corporation Surgical kit for treating prostate tissue
US7595402B2 (en) * 2003-12-16 2009-09-29 Gtx, Inc. Prodrugs of selective androgen receptor modulators and methods of use thereof
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
DK1463497T3 (da) * 2001-12-06 2012-01-30 Gtx Inc Behandling af muskelsvind med selektive androgenreceptormodulatorer
BRPI0307699A2 (pt) * 2002-02-07 2015-06-16 Gtx Inc Tratamento de hiperplasia benigna da próstata com sarms.
US7772433B2 (en) * 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
AU2003217304A1 (en) * 2002-02-28 2003-09-16 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
EP1487458B1 (en) * 2002-02-28 2011-11-16 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
IL163743A0 (en) * 2002-02-28 2005-12-18 Univ Tennessee Res Foundation Haloacetamide and azide substituted compounds and methods of use thereof
US7803970B2 (en) * 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
US7741371B2 (en) * 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7022870B2 (en) * 2002-06-17 2006-04-04 University Of Tennessee Research Foundation N-bridged selective androgen receptor modulators and methods of use thereof
DK1557411T3 (da) * 2002-07-12 2012-11-05 Astellas Pharma Inc N-phenyl-(2r,5s)-dimethylpiperazin-derivat
AU2003287077B2 (en) * 2002-10-15 2007-09-20 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US20040197928A1 (en) * 2002-10-15 2004-10-07 Dalton James T. Method for detecting selective androgen receptor modulators
WO2004034978A2 (en) * 2002-10-15 2004-04-29 Gtx, Inc. Treating obesity with selective androgen receptor modulators
US20060276539A1 (en) * 2002-10-16 2006-12-07 Dalton James T Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
CA2501874A1 (en) * 2002-10-16 2004-04-29 Gtx, Inc. Treating androgen decline in aging male (adam)-associated conditions with sarms
US20040087810A1 (en) * 2002-10-23 2004-05-06 Dalton James T. Irreversible selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040167103A1 (en) * 2003-02-24 2004-08-26 Dalton James T. Haloacetamide and azide substituted compounds and methods of use thereof
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20060258628A1 (en) * 2004-07-20 2006-11-16 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
EA016853B1 (ru) 2006-08-24 2012-08-30 Юниверсити Оф Теннесси Рисерч Фаундейшн Замещенные ациланилиды и их применение
EP2099375B1 (en) 2007-01-02 2014-09-24 AquaBeam LLC Minimally invasive devices for the treatment of prostate diseases
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
US12290277B2 (en) 2007-01-02 2025-05-06 Aquabeam, Llc Tissue resection with pressure sensing
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
US8552061B2 (en) 2007-05-03 2013-10-08 Yale University Locally active “soft” antiandrogens
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EP2259742B1 (en) 2008-03-06 2020-01-01 AquaBeam LLC Tissue ablation and cautery with optical energy carried in fluid stream
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
WO2012109387A1 (en) 2011-02-08 2012-08-16 Halozyme, Inc. Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
EP2819599B1 (en) 2012-02-29 2018-05-23 Procept Biorobotics Corporation Automated image-guided tissue resection and treatment
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
WO2014011220A2 (en) 2012-07-13 2014-01-16 Gtx, Inc. A method of treating androgen receptor (ar)-positive breast cancers with selective androgen receptor modulator (sarms)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
EP2956070A4 (en) 2013-02-14 2016-12-07 Procept Biorobotics Corp METHOD AND DEVICE FOR AQUABLATION AQUABEAM EYE SURGERY
JP6461971B2 (ja) 2013-09-06 2019-01-30 プロセプト バイオロボティクス コーポレイション 飛散パルスを用いた組織切除および処置
BR112016031037B1 (pt) 2014-06-30 2023-02-07 Procept Biorobotics Corporation Aparelho para ablação de tecido vascular
CN107072591B (zh) 2014-09-05 2021-10-26 普罗赛普特生物机器人公司 与靶器官图像的治疗映射结合的医师控制的组织切除

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268684A (fr) * 1960-08-08 1961-08-04 Basf Ag Procédé pour la production d'amides d'acide beta-hydroxypropionique nu-substituéset de leurs esters avec des acides forts, oxygénés
DE1173082B (de) * 1962-06-06 1964-07-02 Bayer Ag Verfahren zur Herstellung von N-mono-substituierten ª‡-Hydroxycarbonsaeureamiden

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197503A (en) * 1962-12-14 1965-07-27 Monsanto Co N-(aryl) oxamic acid chlorides
US3201466A (en) * 1963-03-08 1965-08-17 Gulf Oil Corp Substituted cyclopropanecarboxanilide herbicides
NL123536C (enExample) * 1963-07-09
DE1189312B (de) * 1963-12-06 1965-03-18 Schering Ag Mittel mit selektiver herbizider Wirkung
NL128941C (enExample) * 1964-02-19 1970-06-15
US3426049A (en) * 1965-10-18 1969-02-04 Monsanto Co Nitrotrifluoromethylanilides
US3418345A (en) * 1965-10-18 1968-12-24 Monsanto Co Halonitroanilides
US3462486A (en) * 1966-12-28 1969-08-19 Gulf Oil Corp Method for preparing 3',4'-dichloro-cyclopropanecarboxanilide
US3608087A (en) * 1968-06-21 1971-09-21 Merck & Co Inc Feed compositions
US3723442A (en) * 1970-12-31 1973-03-27 Yoshitomi Pharmaceutical 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
US3720686A (en) * 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268684A (fr) * 1960-08-08 1961-08-04 Basf Ag Procédé pour la production d'amides d'acide beta-hydroxypropionique nu-substituéset de leurs esters avec des acides forts, oxygénés
DE1173082B (de) * 1962-06-06 1964-07-02 Bayer Ag Verfahren zur Herstellung von N-mono-substituierten ª‡-Hydroxycarbonsaeureamiden

Also Published As

Publication number Publication date
US3875229A (en) 1975-04-01
ES420688A1 (es) 1976-09-01
GB1446084A (en) 1976-08-11
AU6270573A (en) 1975-05-22
DE2357757A1 (de) 1974-06-06
FR2207712B1 (enExample) 1976-12-03
IL43664A0 (en) 1974-03-14
JPS4981332A (enExample) 1974-08-06
IE38530B1 (en) 1978-03-29
DD110856A5 (enExample) 1975-01-12
BG21392A3 (enExample) 1976-05-20
HU169277B (enExample) 1976-10-28
IE38530L (en) 1974-05-24
NL7315903A (enExample) 1974-05-28

Similar Documents

Publication Publication Date Title
JPS5033888B2 (enExample)
JPS495599U (enExample)
CH562660A5 (enExample)
BG18764A1 (enExample)
BG18088A1 (enExample)
BG18206A1 (enExample)
BG18288A1 (enExample)
BG18307A1 (enExample)
BG18311A1 (enExample)
BG18359A1 (enExample)
BG18388A1 (enExample)
CH563649A5 (enExample)
CH563082A5 (enExample)
AU479397A (enExample)
BG20493A1 (enExample)
BG20736A1 (enExample)
BG20750A3 (enExample)
BG21622A1 (enExample)
BG26664A4 (enExample)
CH559354A5 (enExample)
CH561908A5 (enExample)
CH561953A5 (enExample)
CH562170A5 (enExample)
CH562618A5 (enExample)
BE783740A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse